Company Profiles

driven by the PitchBook Platform

NewBridge Pharmaceuticals

Description

Developer and manufacturer of specialty therapeutics and devices. The company is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey and Caspian regions (collectively, AfMET) to address the unmet medical needs in diseases with high regional prevalence such as cancer, diabetes, renal and cardiovascular diseases and other metabolic disorders.

2007

Founded

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$48M

Latest Deal Amount

$64M

Total Amount Raised

Description

Developer and manufacturer of specialty therapeutics and devices. The company is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey and Caspian regions (collectively, AfMET) to address the unmet medical needs in diseases with high regional prevalence such as cancer, diabetes, renal and cardiovascular diseases and other metabolic disorders.

Website:

www.nbpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Therapeutic Devices

Primary Office

P.O. Box 500618 Business Central Tower A. Floor 18, Dubai Internet City Dubai United Arab Emirates +971 (0)4 429 8700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NewBridge Pharmaceuticals's full profile, request a free trial.

NewBridge Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NewBridge Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Burrill & CoMerchant Banking FirmMinority000 0000000 0000
ElanCorporationMinority000 0000000 0000
Kuwait Life Sciences CompanyVenture CapitalMinority000 0000000 0000
Burrill & Co Merchant Banking Firm
Elan Corporation
Kuwait Life Sciences Company Venture Capital

NewBridge Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Joseph HeneinPresident, Chief Executive Officer & Board Member
Rosie KhodeirDirector of Business Operations & Strategy
Khaled TamimFinance Director
Vanessa EdmundsVice President of Human Resources and Legal
Baher Massoud MDChief Medical Officer
Joseph Henein President, Chief Executive Officer & Board Member
Rosie Khodeir Director of Business Operations & Strategy
Khaled Tamim Finance Director
Vanessa Edmunds Vice President of Human Resources and Legal
Baher Massoud MD Chief Medical Officer

NewBridge Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Ann Hanham Ph.DBurrill & CoManaging Director000 0000
Chris RoopSelfBoard Member000 0000
Conor WalsheSelfNon Executive Director000 0000
Qais MarafieKuwait Life Sciences CompanyChief Executive Officer & Vice Chairman000 0000
Roger Wyse Ph.DSelfBoard Member000 0000
Ann Hanham Ph.D Managing Director Burrill & Co
Chris Roop Board Member Self
Conor Walshe Non Executive Director Self
Qais Marafie Chief Executive Officer & Vice Chairman Kuwait Life Sciences Company
Roger Wyse Ph.D Board Member Self
Request full access to PitchBook